Richard Hertzberg bought CLRB once, on Apr 15, 2016

Richard Hertzberg is a significant individual shareholder of Cellectar Biosciences, Inc. (NASDAQ: CLRB), reported as a corporate insider and beneficial owner in U.S. Securities and Exchange Commission (SEC) filings.( Ownership data lists Hertzberg among the largest non-institutional holders of Cellectar, with approximately 280,000 shares, representing about 3.5% of the company, classifying him as an insider and Significant Owner rather than an institutional firm.( His insider status is documented in Form 4 filings with the SEC, which identify “Hertzberg Richard” as the reporting person for transactions in Cellectar common stock.(

Publicly available regulatory records describe Hertzberg in his capacity as a reporting owner, providing mailing and business addresses in Wisconsin and California, but do not disclose additional biographical details such as specific professional positions, career history, or education.( As of the information in these filings, Hertzberg’s primary publicly documented role in relation to Cellectar Biosciences is that of a substantial individual investor whose trades must be reported under SEC rules applicable to corporate insiders and significant beneficial owners.(

Written by Perplexity from public sources.